BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 19430488)

  • 21. Signaling, physiological functions and clinical relevance of the G protein-coupled estrogen receptor GPER.
    Prossnitz ER; Barton M
    Prostaglandins Other Lipid Mediat; 2009 Sep; 89(3-4):89-97. PubMed ID: 19442754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. G protein-coupled receptor 30 localizes to the endoplasmic reticulum and is not activated by estradiol.
    Otto C; Rohde-Schulz B; Schwarz G; Fuchs I; Klewer M; Brittain D; Langer G; Bader B; Prelle K; Nubbemeyer R; Fritzemeier KH
    Endocrinology; 2008 Oct; 149(10):4846-56. PubMed ID: 18566127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The G protein-coupled receptor GPR30 mediates the nontranscriptional effect of estrogen on the activation of PI3K/Akt pathway in endometrial cancer cells.
    Ge X; Guo R; Qiao Y; Zhang Y; Lei J; Wang X; Li L; Hu D
    Int J Gynecol Cancer; 2013 Jan; 23(1):52-9. PubMed ID: 23235274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells.
    Thomas P; Pang Y; Filardo EJ; Dong J
    Endocrinology; 2005 Feb; 146(2):624-32. PubMed ID: 15539556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does GPER Really Function as a G Protein-Coupled Estrogen Receptor
    Luo J; Liu D
    Front Endocrinol (Lausanne); 2020; 11():148. PubMed ID: 32296387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Roles of G protein-coupled estrogen receptor in the male reproductive system].
    Chen KH; Zhang X; Jiang XW
    Zhonghua Nan Ke Xue; 2016 Feb; 22(2):175-9. PubMed ID: 26939405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GPR30: a novel therapeutic target in estrogen-related disease.
    Prossnitz ER; Sklar LA; Oprea TI; Arterburn JB
    Trends Pharmacol Sci; 2008 Mar; 29(3):116-23. PubMed ID: 18262661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GPR30 mediates anorectic estrogen-induced STAT3 signaling in the hypothalamus.
    Kwon O; Kang ES; Kim I; Shin S; Kim M; Kwon S; Oh SR; Ahn YS; Kim CH
    Metabolism; 2014 Nov; 63(11):1455-61. PubMed ID: 25200186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GPR30: a seven-transmembrane-spanning estrogen receptor that triggers EGF release.
    Filardo EJ; Thomas P
    Trends Endocrinol Metab; 2005 Oct; 16(8):362-7. PubMed ID: 16125968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of GPR30 in estrogen-induced prostate epithelial apoptosis and benign prostatic hyperplasia.
    Yang DL; Xu JW; Zhu JG; Zhang YL; Xu JB; Sun Q; Cao XN; Zuo WL; Xu RS; Huang JH; Jiang FN; Zhuo YJ; Xiao BQ; Liu YZ; Yuan DB; Sun ZL; He HC; Lun ZR; Zhong WD; Zhou WL
    Biochem Biophys Res Commun; 2017 Jun; 487(3):517-524. PubMed ID: 28412354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hetero-oligomeric Complex between the G Protein-coupled Estrogen Receptor 1 and the Plasma Membrane Ca2+-ATPase 4b.
    Tran QK; VerMeer M; Burgard MA; Hassan AB; Giles J
    J Biol Chem; 2015 May; 290(21):13293-307. PubMed ID: 25847233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estrogen biology: new insights into GPER function and clinical opportunities.
    Prossnitz ER; Barton M
    Mol Cell Endocrinol; 2014 May; 389(1-2):71-83. PubMed ID: 24530924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression and function of the nonclassical estrogen receptor, GPR30, in human cartilage and chondrocytes.
    Ribeiro M; Sousa C; Rufino AT; Judas F; Mendes AF
    J Cell Physiol; 2020 Nov; 235(11):8486-8494. PubMed ID: 32324271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of the GPR30 receptor promotes lordosis in female mice.
    Anchan D; Gafur A; Sano K; Ogawa S; Vasudevan N
    Neuroendocrinology; 2014; 100(1):71-80. PubMed ID: 25012534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Minireview: G protein-coupled estrogen receptor-1, GPER-1: its mechanism of action and role in female reproductive cancer, renal and vascular physiology.
    Filardo EJ; Thomas P
    Endocrinology; 2012 Jul; 153(7):2953-62. PubMed ID: 22495674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estrogenic transmembrane receptor of GPR30 mediates invasion and carcinogenesis by endometrial cancer cell line RL95-2.
    He YY; Du GQ; Cai B; Yan Q; Zhou L; Chen XY; Lu W; Yang YX; Wan XP
    J Cancer Res Clin Oncol; 2012 May; 138(5):775-83. PubMed ID: 22270964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic Signaling.
    Revankar CM; Bologa CG; Pepermans RA; Sharma G; Petrie WK; Alcon SN; Field AS; Ramesh C; Parker MA; Savchuk NP; Sklar LA; Hathaway HJ; Arterburn JB; Oprea TI; Prossnitz ER
    Cell Chem Biol; 2019 Dec; 26(12):1692-1702.e5. PubMed ID: 31706983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of G-Protein Coupled Receptor 30 (GPR30) on Endothelial Inflammation.
    Chakrabarti S; Davidge ST
    Methods Mol Biol; 2016; 1366():503-516. PubMed ID: 26585160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of Estrogen Receptor G Protein-Coupled Receptor 30 Enhances Cholesterol Cholelithogenesis in Female Mice.
    Wang HH; de Bari O; Arnatt CK; Liu M; Portincasa P; Wang DQ
    Hepatology; 2020 Dec; 72(6):2077-2089. PubMed ID: 32112420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interplay of estrogen receptors and GPR30 for the regulation of early membrane initiated transcriptional effects: A pharmacological approach.
    Notas G; Kampa M; Pelekanou V; Castanas E
    Steroids; 2012 Aug; 77(10):943-50. PubMed ID: 22138208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.